Cargando…

Sulodexide in the Treatment of Early Stages of COVID-19

Detalles Bibliográficos
Autores principales:	Gonzalez-Ochoa, Alejandro, Hernandez, Ana, Raffetto, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882918/ http://dx.doi.org/10.1016/j.jvsv.2020.12.012

Ejemplares similares

Sulodexide: A Benefit for Cardiovascular Sequelae of Long COVID Patients?
por: Szolnoky, Győző, et al.
Publicado: (2022)

Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
por: Pompilio, Giuseppe, et al.
Publicado: (2020)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Sulodexide in IgA nephropathy
Publicado: (2013)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19
por: Melkumyants, Arthur, et al.
Publicado: (2022)

Development and use of sulodexide in vascular diseases: implications for treatment
por: Coccheri, Sergio, et al.
Publicado: (2013)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Use of sulodexide in patients with peripheral vascular disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2010)

Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011)

Inhibition of neointimal proliferation of rat carotid artery by sulodexide.
por: Park, H. Y., et al.
Publicado: (1997)

Sulodexide in the treatment of patients with long COVID 19 symptoms and endothelial dysfunction: The results of TUN-EndCOV study
por: Charfeddine, S., et al.
Publicado: (2022)

Targeting the Endothelium in the Treatment of COVID-19 Early Clinical Stages: Results of a Randomized Placebo-Controlled Trial
por: Gonzalez-Ochoa, Alejandro
Publicado: (2021)

A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide
por: Song, Chang Hwa, et al.
Publicado: (2020)

Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review
por: Li, Rui, et al.
Publicado: (2015)

Sulodexide reduces senescence-related changes in human endothelial cells
por: Suminska-Jasinska, Katarzyna, et al.
Publicado: (2011)

Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats
por: Yin, Jianyong, et al.
Publicado: (2016)

Sulodexide reduces glucose induced senescence in human retinal endothelial cells
por: Gericke, A., et al.
Publicado: (2021)

Protective Role of Sulodexide on Renal Injury Induced by Limb Ischemia-Reperfusion
por: Yuan, Tao, et al.
Publicado: (2021)

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Andreozzi, Giuseppe M., et al.
Publicado: (2015)

Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis
por: Bignamini, Angelo A., et al.
Publicado: (2021)

Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
por: Gaddi, Antonio V, et al.
Publicado: (2010)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease
por: Liu, Yu Ning, et al.
Publicado: (2017)

Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy
por: Jo, Hyoung, et al.
Publicado: (2014)

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
por: Broekhuizen, L. N., et al.
Publicado: (2010)

Sulodexide Prevents Hyperglycemia-Induced Endothelial Dysfunction and Oxidative Stress in Porcine Retinal Arterioles
por: Dauth, Alice, et al.
Publicado: (2023)

Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
por: Yongwatana, Kachonsak, et al.
Publicado: (2020)

Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Jiang, Qing-Jun, et al.
Publicado: (2018)

Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats
por: van Haare, Judith, et al.
Publicado: (2017)

Sulodexide for the Symptoms and Signs of Chronic Venous Disease: A Systematic Review and Meta-analysis
por: Bignamini, Angelo A., et al.
Publicado: (2020)

Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis
por: Ying, Jiayun, et al.
Publicado: (2023)

Sulodexide Develops Contraction in Human Saphenous Vein via Endothelium-Dependent Nitric Oxide Pathway
por: Doganci, Suat, et al.
Publicado: (2023)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

The Protective Effect of Sulodexide on Acute Lung Injury Induced by a Murine Model of Obstructive Jaundice
por: Ma, Penglei, et al.
Publicado: (2022)

Correction to: Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet‑induced obese rats
por: van Haare, Judith, et al.
Publicado: (2021)

Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life
por: Elleuch, Nizar, et al.
Publicado: (2016)

Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-β1 and Its Signaling Pathway Molecules
por: Duan, Zhiqiang, et al.
Publicado: (2021)

Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study
por: Charfeddine, Salma, et al.
Publicado: (2022)

The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs
por: Serra, Raffaele, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iruis4p1pe62d5re8vjgh7c864